Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • horribulas
    Junior Member
    • Sep 2015
    • 1

    #1

    Making a in silico mock community

    Hello All!

    I am looking to some microbiome work of fecal samples (16S V4 MiSeq). We are interested in detection a number of specific groups of bacteria in the samples. Specifically E. Coli and different Klebsiella species.

    I would like to know in silico whether we will be able to differentiate between species after we run the sequencing.

    What is the best method for testing whether our V4 sequencing will be able to differentiate to species level? Should I just be doing a bunch of blasting or would making a mock in silico community work best?

    Thanks for any help

    Mark
  • Brian Bushnell
    Super Moderator
    • Jan 2014
    • 2709

    #2
    If you are looking for specific microbial species (or really doing anything with NGS reads), BLAST is not really the best tool. You can calculate abundance by mapping or kmer-matching your sequences to just the set of references of interest.

    And certainly, you should first validate that your approach works on synthetic data before proceeding. That will allow you to quantify true positive, false positive, and false negative rates, which may lead you to adjust your methodology prior to doing any real work.

    For kmer-matching, I recommend Seal (part of the BBMap package), which is fast and easy to use for quantifying sequence expressions levels. For example:

    seal.sh in=reads.fq ref=ecoli.fa,klebsiella1.fa,klebsiella2.fa stats=stats.txt refstats=refstats.txt

    If you generate synthetic reads with errors, and annotate the reads with the name of the organism they came from, you can then objectively calculate the accuracy. Alternatively, if you just want to measure levels of various bacteria, you can generate synthetic reads and mix them in a specific ratio, then evaluate your approach by calculating how closely the output of expression levels matches the ratio of reads you mixed together. That's easier as it does not require parsing the read names.
    Last edited by Brian Bushnell; 09-30-2015, 06:22 PM.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
      by SEQadmin2



      CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

      Despite this, “CRISPR helped turn genome editing from a specialized technique into
      ...
      Yesterday, 11:01 AM
    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM
    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Yesterday, 02:55 AM
    0 responses
    12 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-24-2026, 12:17 PM
    0 responses
    12 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-23-2026, 11:41 AM
    0 responses
    13 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-20-2026, 11:10 AM
    0 responses
    24 views
    0 reactions
    Last Post SEQadmin2  
    Working...